A research team led by scientists at Arizona State University in Tempe has engineered a candidate vaccine that protects mice against Ebola hemorrhagic fever (Phoolcharoen W et al. Proc Natl Acad Sci U S A. 2011;108:20695-20700). This vaccine, which includes the Ebola viral surface glycoprotein fused to a monoclonal antibody that recognizes the glycoprotein, was injected into mice along with polyinosinic:polycytidylic acid (PIC), a chemical that activates a biochemical cascade involved in innate immunity.
Hampton T. Experimental Ebola Vaccine. JAMA. 2012;307(5):446. doi:10.1001/jama.2012.71
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: